FDA approved a new antibiotic to treat community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI).
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.
Here are the top 3 new approvals from FDA.
While Teva Pharmaceutical’s new migraine prevention drug is unique, it faces competition from another major migraine treatment.
Pharmacy and healthcare experts cautiously praised the planned development of a fast-acting, better version of naloxone (Narcan), which is used to reverse the effects of opioid overdoses.
A pharma maker is recalling one lot of an allergy medication because the bottles mistakenly contain this medication.
FDA is warning that a deadly infection has been reported with a widely used class of diabetes drugs.
FDA recently approved a new treatment for 2 rare types of non-Hodgkin lymphomas, as well as a new drug to treat hereditary angiodema and 1 for Fabry disease. Here are the top three new drugs to treat rare diseases.
While FDA approved the first drug containing cannibidiol (CBD), it is cracking down on certain other CBD products marketed as supplements.
The first medication approved by FDA as part of an expedited generic drug program is one that has been in short supply.